The DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index.
The β3 Nicotinic Receptor Subunit: A Component of α-Conotoxin MII-Binding Nicotinic Acetylcholine Receptors that Modulate Dopamine Release and Related Behaviors
Open accessAbstract
Nigrostriatal dopaminergic neurons express many nicotinic acetylcholine receptor (nAChR) subunits capable of forming multiple nAChR subtypes. These subtypes are expressed differentially along the neuron and presumably mediate diverse responses. β3 subunit mRNA has restricted expression but is abundant in the substantia nigra and ventral tegmental areas. To investigate the potential role(s) of nicotinic receptors containing the β3 subunit in dopaminergic tracts, we generated mice with a null mutation in the β3 gene. We were thereby able to identify a population of β3-dependent α-conotoxin MII-binding nAChRs that modulate striatal dopamine release. Changes were also observed in locomotor activity and prepulse inhibition of acoustic startle, behaviors that are controlled, in part, by nigrostriatal and mesolimbic dopaminergic activity, respectively, suggesting that β3-containing nAChRs modulate these behaviors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“As β3 mRNA is detected in the substantia nigra, VTA, and medial habenula (Cui et al. 2003)”
From Nicotine Withdrawal (2015) · cites this paper as Cui et al. 2003
The cited source says what the claim attributes to it.
In the citing paper
“behaviors that are controlled, at least in part, by nigrostriatal and mesolimbic dopaminergic activity (Cui et al. 2003)”
From Nicotine Withdrawal (2015) · cites this paper as Cui et al. 2003
The cited source says what the claim attributes to it.
In the citing paper
“Changes were also reported for locomotor activity and prepulse inhibition of acoustic startle”
From Nicotine Withdrawal (2015) · cites this paper as Cui et al. 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476
Visualizing an Olfactory Sensory Map
Mombaerts, P., Wang, F., Dulac, C. G., Chao, S. K., Nemes, A., Mendelsohn, M. M., Edmondson, J., & Axel, R. (1996) · Cell · doi:10.1016/s0092-8674(00)81387-2 · Cited by 1,992
Geyer, M. A., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100811 · Cited by 1,484
Séguéla, P., Wadiche, J. I., Dineley‐Miller, K., Dani, J., & Jw, P. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-02-00596.1993 · Cited by 1,471
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308
Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08832-7 · Cited by 880
Klink, R., d'Exaerde, A. D. K., Zoli, M., & Changeux, J.-P. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01452.2001 · Cited by 674
Elgoyhen, A. B., Vetter, D. E., Katz, E., Rothlin, C. V., Heinemann, S. F., & Boulter, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051622798 · Cited by 673
Self-citationAbnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain
Picciotto, M. R., Zoli, M., Léna, C., Bessis, A., Lallemand, Y., LeNovère, N., Vincent, P., Pich, E. M., Brûlet, P., & Changeux, J.-P. (1995) · Nature · doi:10.1038/374065a0 · Cited by 668
The new mouse genetics: Altering the genome by gene targeting
Capecchi, M. R. (1989) · Trends in Genetics · doi:10.1016/0168-9525(89)90029-2 · Cited by 611
Cited by
Sorted by citations
Items 101–200 of 214
Grinevich, V. P., Letchworth, S. R., Lindenberger, K. A., Ménager, J., Mary, V., Sadieva, K. A., Buhlman, L. M., Böhme, G. A., Pradier, L., Bénavidès, J., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.075069 · Cited by 44
The α6 nicotinic acetylcholine receptor subunit influences ethanol-induced sedation
Kamens, H. M., Hoft, N. R., Cox, R. J., Miyamoto, J. H., & Ehringer, M. A. (2012) · Alcohol · doi:10.1016/j.alcohol.2012.03.001 · Cited by 43
Luetje, C. W. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1333 · Cited by 43
Brunzell, D. H., McIntosh, J. M., & Papke, R. L. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12421 · Cited by 43
Self-citationWang, S., van der Vaart, A. D., Xu, Q., Seneviratne, C., Pomerleau, O. F., Pomerleau, C. S., Payne, T. J., Ma, J. Z., & Li, M. D. (2013) · Human Genetics · doi:10.1007/s00439-013-1398-9 · Cited by 41
Liu, L., Zhao-Shea, R., McIntosh, J. M., & Tapper, A. R. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.06.015 · Cited by 43
Self-citationKamens, H. M., & Phillips, T. J. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0969-7 · Cited by 40
Progress and challenges in the study of α6-containing nicotinic acetylcholine receptors
Letchworth, S. R., & Whiteaker, P. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.022 · Cited by 40
Self-citationRepérant, C., Pons, S., Dufour, E., Rollema, H., Gardier, A. M., & Maskos, U. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.10.007 · Cited by 41
Acharya, S., & Kim, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094299 · Cited by 40
Azam, L., & McIntosh, J. M. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.071456 · Cited by 37
Self-citationDwoskin, L. P., Wooters, T. E., Sumithran, S. P., Siripurapu, K. B., Joyce, B. M., Lockman, P. R., Manda, V. K., Ayers, J. T., Zhang, Z., Deaciuc, A. G., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.136630 · Cited by 39
Self-citationCox, B. C., Marritt, A. M., Perry, D. C., & Kellar, K. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05282.x · Cited by 43
Mogg, A. J., Jones, F. A., Pullar, I. A., Sharples, C. G. V., & Wonnacott, S. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.013 · Cited by 34
Nasehi, M. M., Mafi, F., Oryan, S., Nasri, S., & Zarrindast, M. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.02.011 · Cited by 37
Cellular events in nicotine addiction
Penton, R. E., & Lester, R. A. J. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.01.001 · Cited by 33
Brunzell, D. H. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts089 · Cited by 36
Comparison of the effects of nicotine and epibatidine on the striatal extracellular dopamine
Janhunen, S. K., & Ahtee, L. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.05.015 · Cited by 32
Parker, M. O., Evans, A., Brock, A. J., Combe, F. J., Teh, M., & Brennan, C. H. (2014) · Addiction Biology · doi:10.1111/adb.12176 · Cited by 31
The Road to Discovery of Neuronal Nicotinic Cholinergic Receptor Subtypes
Collins, A. C., Salminen, O., Marks, M. J., Whiteaker, P., & Grady, S. R. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_4 · Cited by 30
Self-citationLee, A. M., & Messing, R. O. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106277108 · Cited by 30
Cholinergic Receptors and Addiction
Papke, R. L., Brunzell, D. H., & Biasi, M. D. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_139 · Cited by 30
Xu, J., Cohen, B. N., Zhu, Y., Dziewczapolski, G., Panda, S., Lester, H. A., Heinemann, S. F., & Contractor, A. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.78 · Cited by 30
Self-citationLiu, W., & Li, M. D. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170801103009 · Cited by 28
Caruso, M. J., Crowley, N. A., Reiss, D. E., Caulfield, J. I., Lüscher, B., Cavigelli, S. A., & Kamens, H. M. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.01.006 · Cited by 28
Zhu, J., Bardo, M. T., Bruntz, R. C., Stairs, D. J., & Dwoskin, L. P. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05690.x · Cited by 27
Dash, B., Bhakta, M., Chang, Y., & Lukas, R. J. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07685.x · Cited by 26
Wen, L., Yang, Z., Cui, W., & Li, M. D. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.103 · Cited by 27
Visanji, N. P., Mitchell, S. N., O'Neill, M. J., & Duty, S. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.07.013 · Cited by 25
Dash, B., Bhakta, M., Chang, Y., & Lukas, R. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.263673 · Cited by 24
Vivekanandarajah, A., Waters, K. A., & Machaalani, R. (2018) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2018.07.007 · Cited by 25
Wang, Y., Sherwood, J. L., Miles, C., Whiffin, G., & Lodge, D. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706621 · Cited by 23
Gündisch, D., Koren, A. O., Horti, A. G., Pavlova, O. A., Kimes, A. S., Mukhin, A. G., & London, E. D. (2004) · Synapse · doi:10.1002/syn.20096 · Cited by 23
Caruso, M. J., Reiss, D. E., Caulfield, J. I., Thomas, J. L., Baker, A. N., Cavigelli, S. A., & Kamens, H. M. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.08.001 · Cited by 23
Sooksawate, T., & Isa, T. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05190.x · Cited by 22
Molecular Mechanisms Underlying the Motivational Effects of Nicotine
Brunzell, D. H., & Picciotto, M. R. (2008) · Nebraska Symposium on Motivation/The Nebraska symposium on motivation · doi:10.1007/978-0-387-78748-0_3 · Cited by 22
Kamendi, H., Stephens, C. T., Dergacheva, O., Wang, X., Huang, Z.-G., Bouairi, E., Gorini, C., McIntosh, J. M., & Mendelowitz, D. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.03.001 · Cited by 22
Self-citationKamens, H. M., Miyamoto, J. H., Powers, M. S., Ro, K., Soto, M., Cox, R. J., Stitzel, J. A., & Ehringer, M. A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.08.035 · Cited by 21
Self-citationExpression of cloned α6* nicotinic acetylcholine receptors
Wang, J., Kuryatov, A., & Lindstrom, J. M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.009 · Cited by 21
Chronic Nicotine Exposure has Dissociable Behavioural Effects on Control and Beta2−/− Mice
Besson, M., Suárez, S., Cormier, A., Changeux, J., & Granon, S. (2008) · Behavior Genetics · doi:10.1007/s10519-008-9216-1 · Cited by 19
Associations of rare nicotinic cholinergic receptor gene variants to nicotine and alcohol dependence
Zuo, L., Tan, Y., Li, C. R., Wang, Z., Wang, K., Zhang, X., Lin, X., Chen, X., Zhong, C., Wang, X., et al. (2016) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32476 · Cited by 18
Dash, B., Chang, Y., & Lukas, R. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.264044 · Cited by 17
Xu, Y., Wang, J., He, Z., Rao, Z., Zhang, Z., Zhou, T., Zhou, T., & Wang, H. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115980 · Cited by 16
Rasmussen, A., Strøbæk, D., Dyhring, T., Jensen, M. L., Peters, D., Grunnet, M., Timmermann, D. B., & Ahring, P. K. (2013) · Brain Research · doi:10.1016/j.brainres.2013.10.024 · Cited by 16
Vélez-Hernández, M. E., Padilla, E., Gonzalez-Lima, F., & Jiménez‐Rivera, C. A. (2013) · Brain Research · doi:10.1016/j.brainres.2013.10.017 · Cited by 16
Putz, G., Kristufek, D., Orr‐Urtreger, A., Changeux, J., Huck, S., & Scholze, P. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21559 · Cited by 16
Modulation of Gain-of-function α6*-Nicotinic Acetylcholine Receptor by β3 Subunits
Dash, B., & Lukas, R. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.322610 · Cited by 15
Dash, B., Li, M. D., & Lukas, R. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.566018 · Cited by 15
Guildford, M. J., Sacino, A. V., & Tapper, A. R. (2016) · Alcohol · doi:10.1016/j.alcohol.2016.08.006 · Cited by 14
Wang, Q., Li, S., Pan, L., Li, H., Yang, X., Jiang, F., Zhang, N., Han, M., & Jia, C. (2016) · American Journal on Addictions · doi:10.1111/ajad.12383 · Cited by 14
Li, W., Han, H., Liu, Q., Su, K., Yang, Z., Cui, W., Yuan, W., Ma, Y., Fan, R., Chen, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09492-8 · Cited by 15
Nicotinic Acetylcholine Receptors of PC12 Cells
Mussina, K., Toktarkhanova, D., & Filchakova, O. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00846-x · Cited by 15
Nicotinic Acetylcholine Receptors
Lindstrom, J. M. (2010) · Wiley eBooks · doi:10.1002/9780470015902.a0000245.pub2 · Cited by 14
CHRNB3 c.-57A>G functional promoter change affects Parkinson's disease and smoking
Bar‐Shira, A., Gana‐Weisz, M., Gan‐Or, Z., Giladi, E., Giladi, N., & Orr‐Urtreger, A. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.014 · Cited by 13
Madsen, H. B., Koghar, H. S., Pooters, T., Massalas, J. S., Drago, J., & Lawrence, A. J. (2014) · Addiction Biology · doi:10.1111/adb.12148 · Cited by 15
Acetylcholine Receptor Structure
Lindstrom, J. M. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-341-5_2 · Cited by 15
Ley, C. K.-K., Kuryatov, A., Wang, J., & Lindstrom, J. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103244 · Cited by 11
McClure‐Begley, T. D., Wageman, C. R., Grady, S. R., Marks, M. J., McIntosh, J. M., Collins, A. C., & Whiteaker, P. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07759.x · Cited by 11
Self-citationDwoskin, L. P., Pivavarchyk, M., Joyce, B. M., Neugebauer, N. M., Zheng, G., Zhang, Z., Bardo, M. T., & Crooks, P. A. (2008) · Nebraska Symposium on Motivation/The Nebraska symposium on motivation · doi:10.1007/978-0-387-78748-0_4 · Cited by 12
Recent advances in gene manipulation and nicotinic acetylcholine receptor biology
Tammimäki, A., Horton, W. J., & Stitzel, J. A. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.014 · Cited by 10
Self-citationRose, J. E., & Dehkordi, O. (2016) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.1000274 · Cited by 10
Dwoskin, L. P., Joyce, B. M., Zheng, G., Neugebauer, N. M., Manda, V. K., Lockman, P. R., Papke, R. L., Bardo, M. T., & Crooks, P. A. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.021 · Cited by 10
Koob, G. F., & Moal, M. L. (2006) · Elsevier eBooks · doi:10.1016/b978-012419239-3/50043-6 · Cited by 10
Acetylcholine Receptor Structure
Luo, J., & Lindstrom, J. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-73585-6_2 · Cited by 11
Papke, R. L. (2023) · Advances in pharmacology · doi:10.1016/bs.apha.2023.08.001 · Cited by 9
Sumithran, S. P., Crooks, P. A., Xu, R., Zhu, J., Deaciuc, A. G., Wilkins, L. H., & Dwoskin, L. P. (2005) · The AAPS Journal · doi:10.1208/aapsj070119 · Cited by 9
Replicated Risk Nicotinic Cholinergic Receptor Genes for Nicotine Dependence
Zuo, L., García-Milian, R., Guo, X., Zhong, C., Tan, Y., Wang, Z., Wang, J., Wang, X., Kang, L., Lu, L., et al. (2016) · Genes · doi:10.3390/genes7110095 · Cited by 9
Startle response related genes
Zhang, L., Hu, X., Li, H., Li, X., Smerin, S. E., Benedek, D. M., & Ursano, R. J. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.07.018 · Cited by 8
Dash, B., & Li, M. D. (2014) · Molecular Brain · doi:10.1186/1756-6606-7-35 · Cited by 8
Gotti, C., Clementi, F., & Zoli, M. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107067 · Cited by 7
Translational Approaches to Medication Development
Bartlett, S. E., & Heilig, M. A. (2011) · Current topics in behavioral neurosciences · doi:10.1007/978-3-642-28720-6_132 · Cited by 7
The CHRNA6 Gene, Patience, and Voter TurnoutPreprint
Dawes, C. T., & Loewen, P. J. (2009) · SSRN Electronic Journal · doi:10.2139/ssrn.1494509 · Cited by 7
Jackson, A. B., Toma, W. B., Contreras, K. M., Alkhlaif, Y., & Damaj, M. I. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.05.003 · Cited by 6
Proposed mechanisms of neuroprotection for nicotine in Parkinson's disease
Kumari, N., Cooke, L., & Olsen, A. L. (2025) · Journal of Parkinson s Disease · doi:10.1177/1877718x251355112 · Cited by 6
Carreño, D., Facundo, A., Nguyen, M. T. T., & Lotfipour, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073676 · Cited by 5
Ciscato, M., Chouvaeff, M., & Mourot, A. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70352 · Cited by 6
Taylor, D. H. (2013) · Biochemistry & Pharmacology Open Access · doi:10.4172/2167-0501.s1-002 · Cited by 5
Cholinergic Receptor Knockout Mice
Zhang, L. (2006) · Frontiers in neuroscience · doi:10.1201/9781420004335.ch11 · Cited by 4
Presynaptic Nicotinic Acetylcholine Receptors and the Modulation of Circuit Excitability
Zhong, C., López‐Hernández, G. Y., Talmage, D. A., & Role, L. W. (2014) · The Receptors · doi:10.1007/978-1-4939-1167-7_7 · Cited by 4
Fedoseeva, L. A., Ershov, N., Sidorenko, I. A., Markel, А. L., & Redina, O. E. (2022) · Genes · doi:10.3390/genes13091598 · Cited by 3
β2* nAChR sensitivity modulates acquisition of cocaine self-administration in male rats
Walker, N. B., Tucker, B. R., Thomas, L. N., Tapp, A. E., Neel, A. I., Chen, R., Jones, S. R., & Drenan, R. M. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109927 · Cited by 4
Neuronal Nicotinic Receptors: One Hundred Years of Progress
Kellar, K. J., & Xiao, Y. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn004 · Cited by 3
Nicotine and neurocognition in HIV: Translational challenges and therapeutic potential
Jha, N. A., Ayoub, S. M., Brody, A. L., & Young, J. W. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106348 · Cited by 2
Wildeboer, K. M. (2005) · Cited by 2
How can we Improve on Modeling Nicotine Addiction to Develop Better Smoking Cessation Treatments?
Shoaib, M., & Buhidma, Y. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.02.008 · Cited by 2
Conotoxins as Tools in Research on Nicotinic Receptors
Jimenéz, E. C., & Cruz, L. J. (2017) · Toxinology · doi:10.1007/978-94-007-6452-1_17 · Cited by 2
The Influence of Personality Trait on Effective Leadership: The Role of Dopamine
Kurtulmuş, B. E., Katrinli, Ş., & Katrinli, A. E. (2019) · Dokuz Eylül Üniversitesi İşletme Fakültesi Dergisi · doi:10.24889/ifede.433230 · Cited by 5
Effects of Smoking on Hormones, Brain, and Behavior
Sidhartha, T., Poland, R. E., & Rao, U. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00108-x · Cited by 2
Targeting GPR3 as a novel approach for nicotine cessation therapeutic development
Mogul, A. S., Laumann, K. N., Bautista, M. R., Fowler, J., Blough, B. E., Gay, E. A., & Fowler, C. D. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02202-3 · Cited by 1
Choi, Y., Oh, J., Lee, S., Kim, N., Jung, H., Choi, H. K., & Kim, Y. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.120438 · Cited by 1
Presynaptic Nicotinic Acetylcholine Receptors: Subtypes and Functions
Marks, M. J., Grady, S. R., McClure‐Begley, T. D., O’Neill, H. C., & Zambrano, C. A. (2014) · The Receptors · doi:10.1007/978-1-4939-1167-7_4 · Cited by 1
Self-citationAcetylcholine Receptor Structure
Lindstrom, J. M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-156-7_2 · Cited by 1
Conotoxins as Tools in Research on Nicotinic Receptors
Jimenéz, E. C., & Cruz, L. J. (2016) · Springer eBooks · doi:10.1007/978-94-007-6726-3_17-2 · Cited by 1
Conotoxins as Tools in Research on Nicotinic Receptors
Jimenéz, E. C., & Cruz, L. J. (2016) · Springer eBooks · doi:10.1007/978-94-007-6726-3_17-1 · Cited by 1
Nicotinic Receptors in Brain Diseases
Stitzel, J. A. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7104-3_22 · Cited by 1
Self-citationContribution of Variants in CHRNB3/A6 Gene Cluster on Chromosome 8 to Smoking Dependence
Li, M. D. (2018) · Springer eBooks · doi:10.1007/978-981-10-7530-8_6 · Cited by 1
Exley, R. A., Clements, M. A., & Cragg, S. J. (2009) · Advances in behavioral biology · doi:10.1007/978-1-4419-0340-2_25 · Cited by 1
Soll, L. G. (2013) · eScholarship@UMassChan · doi:10.13028/m2ng64
Hendrickson, L. M. (2011) · PubMed · doi:10.13028/174w-zb21
Metadata
- Authors
- Cui, C., Booker, T. K., Allen, R. S., Grady, S. R., Whiteaker, P., Marks, M. J., Salminen, O., Tritto, T., Butt, C. M., Allen, W. R., Stitzel, J. A., McIntosh, J. M., Boulter, J., Collins, A. C., & Heinemann, S. F.
- Affiliations
- Salk Institute for Biological Studies (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2003-12-03
- Volume
- 23
- Issue
- 35
- Pages
- 11045-11053
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6741047
- OpenAlex
- W2130326884
- Cited by
- 213
- References
- 53
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 4 · 2017: 6 · 2016: 10 · 2015: 6 · 2014: 17 · 2013: 9 · 2012: 12
- FWCI
- 5.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k05da000197-07, 5p01da010156-05, MH53631)
- National Institute on Aging (2T32AG00216, T32AG000216)
- National Institute of Mental Health (MH53631, R01MH053631, R29MH053631)
- National Institute on Drug Abuse (DA00197, DA-14369, R01DA014369, R01DA012242, DA10156, DA12242)
- National Institute of Neurological Disorders and Stroke (NS10830, F32NS010830)
- National Institute of Child Health and Human Development
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotinic acetylcholine receptors, beta3 subunit, alpha-conotoxin MII, dopamine release, nigrostriatal pathway, substantia nigra, ventral tegmental area, null mice, locomotor activity, prepulse inhibition, acoustic startle response, mesolimbic dopamine system, striatum
- MeSH terms
- Animals, Behavior, Animal, Binding, Competitive, Corpus Striatum, Dopamine, Dose-Response Relationship, Drug, Female, Ligands, Male, Mice, Mutant Strains, Motor Activity, Neural Inhibition, Nicotine, Receptors, Nicotinic, RNA, Messenger, Reflex, Startle, Substantia Nigra, Synaptosomes, In Situ Hybridization, Mice, Knockout, Gene Targeting, Conotoxins, Protein Subunits, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review